These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14751919)

  • 1. Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment.
    Sculpher M; Bryan S; Fry P; de Winter P; Payne H; Emberton M
    BMJ; 2004 Feb; 328(7436):382. PubMed ID: 14751919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for outcomes associated with surgical management of prostate cancer.
    Smith DS; Krygiel J; Nease RF; Sumner W; Catalona WJ
    J Urol; 2002 May; 167(5):2117-22. PubMed ID: 11956454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer.
    Lloyd A; Penson D; Dewilde S; Kleinman L
    Prostate Cancer Prostatic Dis; 2008; 11(2):153-9. PubMed ID: 17637761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
    Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
    Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The choice between a therapy-induced long-term symptom and shortened survival due to prostate cancer.
    Hopfgarten T; Adolfsson J; Henningsohn L; Onelöv E; Steineck G
    Eur Urol; 2006 Aug; 50(2):280-9. PubMed ID: 16457946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.
    Davison BJ; Oliffe JL; Pickles T; Mroz L
    Oncol Nurs Forum; 2009 Jan; 36(1):89-96. PubMed ID: 19136342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perceptions of quality of life after treatment for early prostate cancer.
    Clark JA; Inui TS; Silliman RA; Bokhour BG; Krasnow SH; Robinson RA; Spaulding M; Talcott JA
    J Clin Oncol; 2003 Oct; 21(20):3777-84. PubMed ID: 14551296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis.
    Seston EM; Ashcroft DM; Griffiths CE
    Arch Dermatol; 2007 Sep; 143(9):1175-9. PubMed ID: 17875880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of remembered International Index of Erectile Function domain scores in men with localized prostate cancer.
    Karakiewicz P; Shariat SF; Naderi A; Kadmon D; Slawin KM
    Urology; 2005 Jan; 65(1):131-5. PubMed ID: 15667878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a prostate sexual rehabilitation clinic: a pilot project.
    Davison BJ; Elliott S; Ekland M; Griffin S; Wiens K
    BJU Int; 2005 Dec; 96(9):1360-4. PubMed ID: 16287458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].
    Soulié M; Villers A; Richaud P; Prapotnich D; Ruffion A; Grosclaude P
    Prog Urol; 2001 Dec; 11(6):1195-204. PubMed ID: 11859652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer diagnosed in spinal cord-injured patients is more commonly advanced stage than in able-bodied patients.
    Scott PA; Perkash I; Mode D; Wolfe VA; Terris MK
    Urology; 2004 Mar; 63(3):509-12. PubMed ID: 15028447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Men's perspectives on the impact of prostate cancer: implications for oncology nurses.
    Fitch MI; Gray R; Franssen E; Johnson B
    Oncol Nurs Forum; 2000 Sep; 27(8):1255-63. PubMed ID: 11013906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls?
    Korfage IJ; de Koning HJ; Habbema JD; Schröder FH; Essink-Bot ML
    BJU Int; 2007 Apr; 99(4):801-6. PubMed ID: 17233804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.
    Potosky AL; Davis WW; Hoffman RM; Stanford JL; Stephenson RA; Penson DF; Harlan LC
    J Natl Cancer Inst; 2004 Sep; 96(18):1358-67. PubMed ID: 15367568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.
    Denberg TD; Melhado TV; Steiner JF
    Cancer; 2006 Aug; 107(3):620-30. PubMed ID: 16802287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experiment.
    McTaggart-Cowan HM; Shi P; Fitzgerald JM; Anis AH; Kopec JA; Bai TR; Soon JA; Lynd LD
    J Asthma; 2008 Oct; 45(8):630-8. PubMed ID: 18951253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis.
    Mold JW; Holtgrave DR; Bisonni RS; Marley DS; Wright RA; Spann SJ
    J Fam Pract; 1992 May; 34(5):561-8. PubMed ID: 1578205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.